Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism IGF-1R antagonists(Insulin-like growth factor I receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Central Nervous System Diseases | Discovery | - | 19 Aug 2022 | |
| Immune System Diseases | Discovery | - | 19 Aug 2022 | |
| Inflammation | Discovery | - | 19 Aug 2022 | |
| Neoplasms | Discovery | - | 19 Aug 2022 |





